Finzati - Logo
APLS logo

Apellis Pharmaceuticals, Inc.

APLS • Biotechnology
$41.03
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$5.17B
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 78.3%Positive free cash flow · 0.36Healthy liquidity · 3.14Expensive earnings multiple · 141.4
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$41.03
Change0.00%
Shares Out126.02M
Market Cap$5.17B
Enterprise Value$5.23B
52W Range16.61 - 41.14
Beta-0.25
P/E38.80
P/S4.68
P/B12.46
P/FCF136.87
EV/Sales4.73

Investment DNA

How strong this company looks for long-term investors

53
out of 100
Business Quality
Margins, moat, returns
41/100
Financial Strength
Debt, cash, stability
65/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
34/100
Why this score▼
Positive revenue growth · 78.3%Positive free cash flow · 0.36Healthy liquidity · 3.14Expensive earnings multiple · 141.4

Analyst view

Analyst sentiment and price target

APLS
Analyst sentiment
Based on 25 analyst votes · 2026-09-05
84/100
Bullish
Bullish
18
Hold
6
Bearish
1
Price Target
2026-06-05
Low
$19.00
Mean
$33.40
Median
$35.00
High
$48.00

Company Overview

IPO: 11/9/2017
Industry: Biotechnology
P/B i: 12.46
Debt / Equity i: 1.31
Operating Margin: 5.52%
Net Margin: 2.23%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: 1.31
Current Ratio: 3.14
Quick Ratio: 2.70
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 3 high-volume insider sells detected
Baumal Caroline
Transaction: 05/14/2026
SELL
Change
-37,000
Price
$66.30
Filing
05/14/2026
Type
SELL
Baumal Caroline
Transaction: 05/14/2026
SELL
Change
-86,525
Price
$0.00
Filing
05/14/2026
Type
SELL
Francois Cedric
Transaction: 05/14/2026
SELL
Change
-273,779
Price
$13.85
Filing
05/14/2026
Type
SELL